Laxmi Organic Industries Ltd
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited.
The company’s business operations are carried in over 30 countries including 11 offices located in India
- Market Cap ₹ 4,814 Cr.
- Current Price ₹ 173
- High / Low ₹ 241 / 107
- Stock P/E 40.2
- Book Value ₹ 71.7
- Dividend Yield 0.17 %
- ROCE 4.90 %
- ROE 4.09 %
- Face Value ₹ 2.00
Pros
Cons
- The company has delivered a poor sales growth of 11.8% over past five years.
- Company has a low return on equity of 6.02% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 11.7% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.05%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 902 | 1,008 | 1,273 | 1,429 | 1,359 | 1,606 | 2,877 | 2,691 | 2,824 | 2,945 | 2,809 | 3,094 | |
| 825 | 892 | 1,124 | 1,275 | 1,239 | 1,401 | 2,541 | 2,444 | 2,566 | 2,655 | 2,634 | 2,847 | |
| Operating Profit | 76 | 116 | 149 | 154 | 120 | 205 | 337 | 247 | 258 | 289 | 175 | 247 |
| OPM % | 8% | 12% | 12% | 11% | 9% | 13% | 12% | 9% | 9% | 10% | 6% | 8% |
| 3 | 2 | 4 | 6 | 33 | 9 | 21 | 29 | 29 | 19 | 14 | 13 | |
| Interest | 18 | 11 | 10 | 16 | 15 | 18 | 17 | 22 | 6 | 20 | 22 | 21 |
| Depreciation | 28 | 27 | 29 | 41 | 48 | 45 | 47 | 70 | 105 | 122 | 75 | 80 |
| Profit before tax | 32 | 81 | 113 | 103 | 90 | 151 | 294 | 183 | 176 | 166 | 93 | 160 |
| Tax % | 23% | 12% | 32% | 24% | 13% | 19% | 18% | 27% | 28% | 29% | 14% | |
| 25 | 71 | 77 | 78 | 79 | 123 | 240 | 135 | 127 | 118 | 79 | 120 | |
| EPS in Rs | 24.56 | 70.71 | 76.66 | 15.54 | 17.46 | 4.65 | 9.09 | 5.08 | 4.62 | 4.26 | 2.86 | 4.31 |
| Dividend Payout % | 4% | 0% | 0% | 2% | 10% | 11% | 8% | 10% | 13% | 12% | 10% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 1% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | -8% |
| 3 Years: | -16% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -14% |
| 3 Years: | -13% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 50 | 45 | 53 | 53 | 53 | 55 | 55 | 55 |
| Reserves | 224 | 294 | 370 | 405 | 396 | 992 | 1,230 | 1,367 | 1,745 | 1,857 | 1,933 |
| 199 | 79 | 194 | 143 | 138 | 75 | 99 | 372 | 139 | 255 | 541 | |
| 158 | 227 | 258 | 359 | 445 | 616 | 785 | 537 | 880 | 874 | 909 | |
| Total Liabilities | 590 | 610 | 832 | 958 | 1,024 | 1,735 | 2,166 | 2,329 | 2,820 | 3,040 | 3,438 |
| 207 | 195 | 273 | 327 | 327 | 315 | 361 | 694 | 872 | 1,161 | 1,499 | |
| CWIP | 33 | 48 | 30 | 31 | 23 | 60 | 177 | 88 | 459 | 419 | 652 |
| Investments | 19 | 23 | 20 | 20 | 21 | 25 | 32 | 287 | 149 | 167 | 56 |
| 332 | 344 | 509 | 579 | 653 | 1,335 | 1,597 | 1,259 | 1,341 | 1,294 | 1,232 | |
| Total Assets | 590 | 610 | 832 | 958 | 1,024 | 1,735 | 2,166 | 2,329 | 2,820 | 3,040 | 3,438 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 135 | 110 | 61 | 161 | 521 | 114 | 173 | |||||
| -3 | -604 | 44 | -362 | -494 | -274 | -404 | |||||
| -115 | 485 | -87 | 241 | -10 | 91 | 248 | |||||
| Net Cash Flow | 17 | -9 | 17 | 40 | 16 | -68 | 17 | ||||
| Free Cash Flow | 102 | 22 | -116 | -150 | 269 | -286 | -430 | ||||
| CFO/OP | 125% | 66% | 33% | 82% | 218% | 48% | 104% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 78 | 83 | 78 | 85 | 87 | 79 | 73 | 78 | 67 | 69 |
| Inventory Days | 61 | 34 | 51 | 48 | 57 | 59 | 60 | 50 | 48 | 68 | 67 |
| Days Payable | 70 | 85 | 83 | 112 | 154 | 155 | 127 | 93 | 146 | 133 | 141 |
| Cash Conversion Cycle | 52 | 27 | 51 | 13 | -12 | -8 | 12 | 30 | -20 | 3 | -5 |
| Working Capital Days | 12 | 16 | 25 | 27 | 34 | 5 | 42 | 33 | 18 | 11 | 31 |
| ROCE % | 22% | 26% | 20% | 14% | 20% | 25% | 13% | 9% | 9% | 5% |
Insights
In beta| Mar 2017 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Active Customers count |
|
|||||
| Diketene Derivatives Market Share in India % |
||||||
| Diketene Product Portfolio Size count |
||||||
| Ethyl Acetate Market Share in India % |
||||||
| R&D Headcount count |
||||||
| Essentials (Ethyl Acetate + Acetaldehyde) Production Capacity MTPA |
||||||
| Export Revenue Share % of revenue |
||||||
| Total Volume Growth (YoY) % |
||||||
| R&D Expenditure (Percentage of Turnover) % |
||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Management
- CPO Dr. Keshav Ruthia and CTO Salil Mukundan resign, effective October 31, 2026.
- Allotment Of Shares Under Employee Stock Options As Per Laxmi - Employee Stock Option Plan 2020 ('ESOP-2020')
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- Laxmi Organic held its 37th AGM on August 5, 2026; final dividend approved, voting results due within two days.
-
Announcement Under Regulation 30 -SEBI (LODR), 2015
- Laxmi Organic held Q1 FY27 investor call; revenue rose 40% to INR9,683 million, EBITDA 272% to INR1,143 million.
Annual reports
Concalls
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
May 2025TranscriptAI SummaryPPT
-
Jan 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jul 2024TranscriptAI SummaryPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT REC
-
Oct 2023TranscriptAI SummaryPPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptAI SummaryPPT
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptAI SummaryPPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptAI SummaryPPT
-
May 2022TranscriptAI SummaryPPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
-
May 2021Transcript PPT
Product Portfolio[1]
a) Essentials Segment
The Segment includes products like Ethyl Acetate, Acetic Anhydride, Acetaldehyde, various solvents, ethanol, and n-Butyl/Ethyl Acetate. These cater primarily to the pharmaceutical, packaging, and industrial sectors.